证券日报网讯12月16日，儒竞科技（301525）在互动平台回答投资者提问时表示，公司以持续高研发投 入为支撑，在HVAC/R、新能源汽车热管理、伺服驱动及控制系统三大核心领域掌握多项自主创新技 术，拥有200余项专利技术及软件著作权成果。2025年前三季度，公司研发投入同比增长15.07%，占当 期营业收入的9.87%，持续加码核心技术攻坚与产品迭代升级，在数据中心、工控、机器人等新兴领域 不断加大研发布局，持续优化产品结构，以提升公司核心竞争力。具体技术和产品情况请关注公司发布 的定期报告和相关公告。 ...

Core Viewpoint - The company, Maike Bio (300463), has successfully developed and produced its fully automated biochemical analysis systems, which have been recognized in the Sichuan Province's innovation medical device integration application pilot project [1] Group 1: Company Innovations - The fully automated biochemical analysis systems are entirely self-produced by the company [1] - The C2000/C1000 fully automated biochemical analysis system represents a breakthrough in independent innovation technology in the biochemical testing field [1] - The innovation effectively addresses the technical pain points of frequent validation in medical laboratory biochemical analysis [1]